• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT INSULIN Back to Search Results
Catalog Number 08K41-26
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
There was no further patient information provided by the customer.An evaluation is in process.A final report will be submitted when the evaluation is complete.
 
Event Description
The customer reported false elevated insulin results for a (b)(6) year old female patient when processing on the architect i2000.The following data was provided: baseline 30 uu/ml.30 min 60 uu/ml.60 min 116 uu/ml 120 min 267 uu/ml the customer stated the results were not consistent with the patient's medical history and were questioned by the physician.Additional patient history provided was an (b)(6) value of 6.3%.The customer did not provide their reference range.No patient harm was reported.No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets determined that there are no other complaints for lot 11020lp41 and there were no trends identified for the product for the issue.Return testing was not completed as returns were not available.Accuracy testing was performed with a retained kit of lot 11020lp41 and an internal insulin panel.All acceptance criteria were met, which indicates acceptable product performance.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on our investigation no product deficiency was identified for the architect insulin reagent, lot 11020lp41.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN
Type of Device
INSULIN
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
MDR Report Key9953770
MDR Text Key228604009
Report Number1415939-2020-00033
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 05/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/13/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/23/2020
Device Catalogue Number08K41-26
Device Lot Number11020LP41
Was Device Available for Evaluation? No
Date Manufacturer Received05/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LN 03M74-01, SERIAL (B)(6); LN 03M74-01, SERIAL (B)(6)
Patient Age70 YR
-
-